Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | PPID | Q08752 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | NCF1 | P14598 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.35 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.35 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23135415 | 0.90 | RAB9A (0.36) | NPC1RAB9ASMN1; SMN2KMT2APPID | |
| SCHEMBL23135417 | 0.81 | PPID (0.55) | PPIDALDH1A1EPHX2TPSAB1TPSD1 | |
| SCHEMBL26158515 | 0.79 | HRH3 (0.42) | RAB9ASMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL23135392 | 0.73 | ADRA2A (0.41) | NPC1RAB9ASMN1; SMN2ALDH1A1TPSAB1 | |
| SCHEMBL23135383 | 0.73 | PPID (0.50) | PPIDALDH1A1EPHX2TPSAB1TPSD1 | |
| SCHEMBL19882168 | 0.73 | PPID (0.71) | RAB9APPIDALDH1A1NAMPTPOLB | |
| SCHEMBL14703240 | 0.72 | MEN1 (0.46) | NPC1RAB9ASMN1; SMN2KMT2AALDH1A1 | |
| SCHEMBL23135376 | 0.70 | NPC1 (0.38) | NPC1RAB9ASMN1; SMN2ALDH1A1EPHX2 | |
| SCHEMBL14703438 | 0.70 | KCNH2 (0.42) | SMN1; SMN2KMT2AALDH1A1MAPTMEN1 | |
| SCHEMBL14703246 | 0.70 | SMN1; SMN2 (0.44) | NPC1RAB9ASMN1; SMN2KMT2APPID |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230264171-A1 | CHROMATOGRAPHY RESIN HAVING AN ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE LIGAND | BIO-RAD LABORATORIES, INC. | 2023-08-24 | — | — | US | disclosed |
| US-20230264171-A1 | CHROMATOGRAPHY RESIN HAVING AN ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE LIGAND | BIO-RAD LABORATORIES, INC. | 2023-08-24 | — | — | US | disclosed |
| US-11666888-B2 | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand | BIO-RAD LABORATORIES, INC. (US) | 2023-06-06 | — | — | US | disclosed |
| US-11666888-B2 | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand | BIO-RAD LABORATORIES, INC. (US) | 2023-06-06 | — | — | US | disclosed |
| US-20210086165-A1 | CHROMATOGRAPHY RESIN HAVING AN ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE LIGAND | BIO-RAD LABORATORIES, INC. | 2021-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11666888-B2 | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand | MSR1, RXRA, MLX | NPC1 1303/4885RAB9A 2059/4885SMN1; SMN2 4015/4885 |
| US-20230264171-A1 | CHROMATOGRAPHY RESIN HAVING AN ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE LIGAND | MSR1, RXRA, MLX | NPC1 1303/4885RAB9A 2059/4885SMN1; SMN2 4015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.